Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma

Icaritin is a potential treatment option for hepatocellular carcinoma (HCC) based on the results of its phase 2 stage trial. Glucose transporter 1 (GLUT1), a critical gene in regulating glycolysis, has been recognized as a promising target in HCC treatment. Previous studies have reported that FAM99A...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xia, Gou, Yudong, Jiang, Ziyu, Yang, Aizhen, Yang, Zhihui, Qin, Shukui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576446/
https://www.ncbi.nlm.nih.gov/pubmed/34765550
http://dx.doi.org/10.3389/fonc.2021.740557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576446/
https://www.ncbi.nlm.nih.gov/pubmed/34765550
http://dx.doi.org/10.3389/fonc.2021.740557

Ejemplares similares